Verseon Priced, AIM: VSN.LN

Biotech targeting oral anticoagulants, diabetic retinopathy and solid tumors.

Industry: Health Care

Latest Trade: $1.53 0.00 (0.0%)

First Day Return: -30.1%

Return from IPO: -50.3%

Industry: Health Care

Biotech targeting oral anticoagulants, diabetic retinopathy and solid tumors.
more less
IPO News for Verseon
more
IPO Data
IPO File Date 05/01/2015
Offer Price $3.07
Price Range $3.07 - $3.07
Offer Shares (mm) 32.6
Deal Size ($mm) $100
IPO Data
IPO Date 05/01/2015
Offer Price $3.07
Price Range $3.07 - $3.07
Offer Shares (mm) 32.6
Deal Size ($mm) $100
Underwriters
more
Company Data
Headquarters Fremont,
Founded
Employees n/a
Website